Skip to content

The efficacy of an intervention for post traumatic stress disorder among illicit drug users

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN12908171
Enrollment
150
Registered
2007-05-15
Start date
2007-04-23
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post traumatic stress disorder and substance use disorders Mental and Behavioural Disorders Post traumatic stress disorder and substance use disorders

Interventions

The treatment group will receive an integrated treatment for PTSD and substance dependence called 'Concurrent Treatment with Prolonged Exposure'. Concurrent Treatment with Prolonged Exposure involves

Sponsors

National Health and Medical Research Council (Australia)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. 18 years of age or older 2. Lifetime exposure to at least one traumatic event 3. Screen positive for current (past month) PTSD 4. Use of drugs other than alcohol at least four times in the past month 5. Literate in English 6. Willing to give locator information

Exclusion criteria

Exclusion criteria: 1. Current suicidality or recent self-harming behaviours 2. Chronic psychosis 3. Cognitive impairment sufficient to interfere with therapy

Design outcomes

Primary

MeasureTime frame
Reduction in PTSD symtpoms and drug use will be measured at 6 weeks, 3 and 9 months post-baseline.

Secondary

MeasureTime frame
Improvements in other treatment outcomes including their overall physical and mental health will also be measured at 6 weeks, 3 and 9 months post-baseline using the following: 1. Short Form 12 questionnaire (for assessment of general physical and mental health) 2. Beck Depression Inventory II 3. State Trait Anxiety Inventory

Countries

Australia

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 25, 2026